Equol: Clinical Trials

7 trials of Equol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 recruiting, 1 active not recruiting, 1 unknown. 7 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 27Completed 3, Recruiting 2, Active not recruiting 1, Unknown 1
Phase 12Completed 1, Unknown 1

Follow Equol: new trials by email Literature Review of Equol trials Research Report on Equol

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Equol and Vascular Function in Women With Chronic Kidney Disease
Equol, Placebo - Chronic Kidney Disease (Stage 3-4), Vascular Function
Phase 2RecruitingUniversity of Colorado, Denver742026-02-192026-06-02
Effect of Equol Supplementation on Arterial Stiffness and Cognition in Healthy Volunteers
S-equol, Placebo - Arterial Stiffness, White Matter Lesions
Phase 2Active not recruitingAkira Sekikawa3692023-06-292026-08-20
Acute Equol Supplementation and Vascular Function in Women With and Without CKD
S-equol, Placebo - Chronic Kidney Diseases, Vascular Function
Phase 2RecruitingUniversity of Colorado, Denver382023-03-072025-09-30
S-Equol in Alzheimer's Disease 2 Trial
S-equol and Placebo, Placebo and S-equol - Alzheimer Disease
Phase 1 / Phase 2CompletedRussell Swerdlow402017-05-052024-07-25
A Novel Combination Oral Agent to Treat Acne Vulgaris
Doxycycline and S-equol, Doxycycline - ACNE VULGARIS
Phase 1 / Phase 2UnknownNexgen Dermatologics, Inc.602010-11-012011-02-23
Efficacy and Safety of S-equol on Vasomotor Symptoms in Menopausal Patients
Placebo, S-equol - Menopause
Phase 2CompletedAusio Pharmaceuticals, LLC1692010-06-012014-04-08
Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia
S-equol, Placebo - Benign Prostatic Hyperplasia
Phase 2CompletedAusio Pharmaceuticals, LLC1162009-06-012017-05-19

Conditions studied

Alzheimer Disease (2)  ·  Renal Insufficiency, Chronic (2)  ·  Acne Vulgaris (1)  ·  Cognitive Dysfunction (1)  ·  Dementia (1)  ·  Prostatic Hyperplasia (1)

Sponsors

Ausio Pharmaceuticals, LLC (2)  ·  University of Colorado, Denver (2)  ·  Akira Sekikawa (1)  ·  Nexgen Dermatologics, Inc. (1)  ·  Russell Swerdlow (1)

Countries

United States (7)  ·  Australia (1)  ·  India (1)

Top investigators

Akira Sekikawa, MD, PhD, PhD (1)  ·  Donald Bergner, MD (1)  ·  Joshua M Berlin, MD (1)  ·  Michael A Thomas, MD (1)  ·  Russell Swerdlow, MD (1)

Results publications

PMID 40838083

NIH funding

R01AG074971 (1)